NIFTY 50▲24,769.10
363.00 (1.49%)
SENSEX▲81,089.38
1049.58 (1.31%)
NIFTY BANK▲51,146.25
257.50 (0.51%)
INDIAN RAILWAY FINANCE CORP▲184.17
0.61 (0.33%)
TATA MOTORS▲1,107.20
16.25 (1.49%)
TATA STEEL▲162.73
5.34 (3.39%)
TATA POWER▲442.95
19.60 (4.63%)
SUZLON ENERGY▲61.63
0.16 (0.26%)
RAIL VIKAS NIGAM▼553.70
-22.00 (-3.82%)
INDIAN RENEWABLE ENERGY▼259.20
-1.98 (-0.76%)
VODAFONE IDEA▲15.91
0.73 (4.81%)
RELIANCE INDUSTRIES▲3,009.70
24.90 (0.83%)
YES BANK▲24.93
0.31 (1.26%)
ADANI POWER▲713.60
18.40 (2.65%)
NHPC▲104.40
2.44 (2.39%)
STATE BANK OF INDIA▲857.60
9.10 (1.07%)
HDFC BANK▼1,615.15
-1.45 (-0.09%)
RELIANCE POWER▲29.88
0.19 (0.64%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲220.49
1.18 (0.54%)
ADANI PORT & SEZ▲1,537.50
50.50 (3.40%)
BHARAT ELECTRONICS▲309.00
7.55 (2.50%)
INDIAN RAILWAY TOURISM CORP▲981.45
12.30 (1.27%)
INDIAN OIL CORP▼176.83
-0.02 (-0.01%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,351.00
760.90 (0.55%)
ADANI ENTERPRISES▲3,080.45
106.95 (3.60%)
JAIPRAKASH POWER VENTURES▲19.22
0.39 (2.07%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. stocks list
    apple-store
  4. BETA DRUGS LIMITED
stock logo

BETA DRUGS LIMITED Share Price

BETA

₹1,320.00+₹48.15 (3.79%) TodayLast updated on 26 Jul, 2024 | 13:50 IST
₹1,291.00₹1,352.30
L
Show Current Price
H

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹1,278 Crs

Open

₹1,352.30

Close

₹1,271.85

Circuit range

₹1,526.20 - ₹1,017.50

Day range

₹1,291.00 - ₹1,352.30

Year range

₹728.00 - ₹1,595.00

Volume

4,600

Avg. traded

₹1,311.88

Revenue (12m)

₹296 Crs

BETA DRUGS LIMITEDBeta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, lung, head, and neck, colorectal, ovarian, gastric, brain, testicular renal, prostate, leukemia, lymphoma, myeloma, supportive. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ARBAZ, FISTENT, BUSFAN, Triodelta and others. The Company's subsidiaries include Adley Lab Limited, Adley Formulations Private Limited.

BETA DRUGS LIMITED Key indicators

arrow

52 week high

₹1,595.00

52 week low

₹728.00

P/E ratio

35.08

P/B ratio

7.78

ROE

21.66%

ROCE

27.93%

Dividend yield

--

Debt/Equity ratio

0.06

EPS

19.57

Learn more

Investment checklist: (5/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

20.42%

Net profit margin

11.92%

ROE

21.66%

ROA

14.97%

ROCE

27.93%

Learn more

BETA DRUGS LIMITED Shareholder returns

arrow

1 day

-1.92%

1 week

+3.31%

1 month

+7.58%

3 months

-5.11%

1 year

+78.11%

3 years

+234.36%

5 years

+1416.10%

BETA DRUGS LIMITED Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 25 2024
₹1,305.00
₹1,271.85
-2.45%
Wed, Jul 24 2024
₹1,330.00
₹1,303.85
-1.92%
Tue, Jul 23 2024
₹1,295.00
₹1,329.40
+2.18%
Mon, Jul 22 2024
₹1,260.00
₹1,301.05
+0.04%
Fri, Jul 19 2024
₹1,282.15
₹1,300.55
+1.44%
Thu, Jul 18 2024
₹1,280.00
₹1,282.15
+1.59%
Tue, Jul 16 2024
₹1,204.05
₹1,262.10
+4.01%
Mon, Jul 15 2024
₹1,218.00
₹1,213.45
+1.31%

Shareholding info

arrow

Promoters (66.73%)

Mutual Funds (0%)

Retail and other (32.91%)

Foreign institutions-FII (0.32%)

Other domestic institutions (0.04%)

Promoters

Learn more

Frequently asked questions